Daily Industry Report - May 13

Your summary of the Voluntary and Healthcare Industry’s most relevant and breaking news; brought to you by the Health & Voluntary Benefits Association®

Jake Velie, CPT
Vice Chairman & President
Health & Voluntary Benefits Association® (HVBA)
Editor-In-Chief
Daily Industry Report (DIR)

Robert S. Shestack, CCSS, CVBS, CFF
Chairman & CEO
Health & Voluntary Benefits Association® (HVBA)
Publisher
Daily Industry Report (DIR)

White House unveils sweeping plan to try to lower U.S. drug prices

By Daniel Payne - The Trump administration on Monday unveiled a sweeping plan that aims to lower prescription drug prices — but its impact on the pharmaceutical industry remains to be seen. The plan relies on drugmakers striking deals with the U.S. government to lower their prices, with a threat of new government regulation and legal investigations if they don’t. Read Full Article… (Subscription required)

HVBA Article Summary

  1. International Price Benchmarking and Enforcement Leverage: The executive order aims to lower U.S. drug prices by tying them to the lowest prices paid in economically comparable countries—a “most favored nation” strategy. If drugmakers don't agree to price reductions, the administration plans to use HHS rulemaking and Medicare leverage to force prices down. Enforcement measures may also include increased importation of cheaper drugs and stricter action on anti-competitive practices by the DOJ and FTC.

  2. Trade Pressure and Global Price Rebalancing Strategy: Trump’s administration intends to use trade policy to pressure foreign governments into allowing drug prices to rise abroad, arguing that other nations have long suppressed prices artificially. The U.S. will deploy agencies like the U.S. Trade Representative and Department of Commerce to challenge these practices, with expectations that international prices will increase while U.S. prices fall, particularly for high-cost drugs like GLP-1s.

  3. Market Response and Legal Pushback Anticipated: Despite the aggressive tone of the order, markets responded positively, suggesting skepticism about the plan’s enforceability—given that similar past efforts stalled legally or bureaucratically. Industry groups like PhRMA and BIO criticized the plan as harmful to innovation and national interests, warning of increased reliance on China. Legal challenges are expected, with some companies already preparing responses. Analysts caution that the financial impact will hinge on regulatory follow-through and litigation outcomes.

LAST CHANCE TO SECURE YOUR SPOT

HVBA Poll Question - Please share your insights

Do you offer pet insurance options to your customers?

Login or Subscribe to participate in polls.

Our last poll results are in!

28.66%

Of Daily Industry Report readers who participated in our last polling question, when asked, “What is the biggest barrier to addressing diabetes in the workplace?” responded with ” Insufficient employer support for comprehensive health programs.

24.43% stated that their biggest barrier to addressing diabetes in the workplace was “high costs associated with diabetes care and management,24.27% of poll participants stating " limited access to healthcare services and resources for employees.” The remaining 22.64% identified “lack of awareness about available diabetes prevention and management programs” as their primary barrier.

Have a poll question you’d like to suggest? Let us know!

Hope, Then Heartbreak: Cigna Denies Life-Saving Transplant at the Last Minute

By Wendell Potter - Imagine for a moment that you’re Deron Wells — a 59-year-old husband, father of three, and once-healthy man now fighting for his life with stage 4 lung cancer. You’ve endured the agony of a terminal diagnosis. You’ve cleared the hurdles of medical approval for a rare, double-lung transplant. You’ve clung to hope, arranged travel from California to Chicago, and prepared to leave the hospital for the chance to breathe again — literally. Read Full Article… (Subscription required)

HVBA Article Summary

  1. Insurer Denial Despite Prior Approval: Deron Wells believed his life-saving organ transplant had been approved by Cigna, only to be denied at the last minute, just as his family was preparing to transfer him to Northwestern Medicine. This echoes past tragedies, including the 2007 death of Nataline Sarkisyan, and reflects a persistent pattern of insurers overriding physician-recommended care based on opaque internal policies.

  2. Profits Over Patients: Cigna defended its decision by citing "coverage guidelines grounded in national clinical standards," the same rationale it used while denying tens of thousands of claims through automated systems. In 2024, Cigna made nearly $8 billion in profits and awarded its CEO over $23 million in compensation, raising questions about whether financial interests are prioritized over patient lives.

  3. Crowdfunding as a Failing Safety Net: Like many Americans facing coverage denials, Wells now relies on a GoFundMe campaign to afford essential medical care. With roughly one-third of all GoFundMe campaigns now for health-related expenses, the story underscores how insurance gaps force individuals to depend on public donations for survival — a symptom of a deeply broken healthcare system.

Trump takes on Big Pharma with new executive order calling for U.S. to match lower prices abroad

By Allison Bell - President Donald Trump today signed an executive order that could give U.S. patients the ability to buy drugs from the lowest-cost willing providers in the world. The order calls for U.S. Health and Human Services Secretary Robert F. Kennedy Jr. to set up a mechanism that patients here can use to bypass existing U.S. drug distribution arrangements and buy drugs directly from pharmacies in places like France, Germany or the United Kingdom that may charge much less for the drugs than U.S. pharmacies charge. Read Full Article… (Subscription required)

HVBA Article Summary

  1. Push for "Most Favored Nation" Pricing: The executive order asserts that Americans—who help fund much of the world’s pharmaceutical research—should not pay more than patients in other developed countries for the same drugs. It instructs officials to pursue trade and regulatory strategies ensuring the U.S. secures the best pricing globally, including pressuring foreign nations not to contribute to inflated U.S. drug costs.

  2. Coordinated Federal Action and Contingency Measures: The order directs multiple federal agencies, including the U.S. Trade Representative, Commerce Secretary, FTC, and Attorney General, to work in tandem to reduce drug costs. If legal barriers obstruct implementing most-favored-nation pricing, the administration is empowered to pursue alternative aggressive actions to lower prices and curb anti-competitive behavior in the pharmaceutical industry.

  3. Challenges and Market Dynamics: Although similar strategies have faced implementation challenges in Europe—where companies have used secret rebates and product variations to game pricing benchmarks—experts note that the U.S. market’s size and influence could make such strategies more effective here. Nonetheless, price transparency poses both opportunities for savings and risks of collusion in a concentrated drug market.

Rising stress demands employer action on mental health

By Alex Powell - From technological evolution to economic uncertainty, the world is changing at a pace never seen before – and understandably, people are more stressed as a response. A 2024 poll from the American Psychiatric Association found that U.S. adults are feeling increasingly anxious, with 43% of adults reporting feeling more anxious than the previous year. Read Full Article… (Subscription required) 

HVBA Article Summary

  1. Widespread Workplace Stress: A striking 84% of U.S. workers report that their workplace has contributed to at least one mental health challenge, with 32% frequently experiencing stress and 25% facing full burnout. This underscores the urgent need for employers to address mental health proactively—not just as a wellness initiative, but as a business necessity to reduce absenteeism, turnover, and lost productivity.

  2. The Role of Managers and Culture: Managers are crucial in identifying and alleviating employee stress by providing emotional support, recognizing accomplishments, and fostering open communication. Companies that equip leaders with mental health training and emphasize empathy, trust, and flexibility are more likely to cultivate cultures of appreciation and reduce burnout among employees.

  3. Meaningful Benefits and Flexibility: Mental health benefits remain highly valued, yet underprovided—while 90% of employees consider them important, only 35% report having access. Employers can make a meaningful difference by offering flexible work arrangements, confidential counseling, comprehensive coverage for therapy and psychiatric care, and by listening to employee feedback to tailor offerings that prioritize wellbeing over marginal pay increases. 

AI health risk assessments aim to boost Medicare Advantage pay

By Nona Tepper - Health insurance companies are incorporating artificial intelligence into a health screening tool that can turbocharge Medicare Advantage revenue. AI agents from Zing Health and other insurers perform automated health risk assessments over the telephone that feature general and personalized questions on subjects such as physical health, mental well-being and transportation to medical appointments. Read Full Article…

HVBA Article Summary

  1. AI-Driven Health Risk Assessments Enhance Efficiency and Revenue: Medicare Advantage insurers are increasingly using AI to streamline health risk assessments, enabling quicker and more scalable evaluations. This supports early clinical interventions while boosting risk-adjustment payments, with CMS allocating billions based on diagnoses collected through these tools—even those not tied to claims.

  2. Low-Cost Tools Yield High Financial Returns: Insurers offer small incentives (like $100 gift cards) to boost participation in health risk assessments, which can lead to significant payoffs. In 2023 alone, $7.5 billion in payments were tied to diagnoses gathered exclusively through these assessments or chart reviews, underscoring their profitability for insurers.

  3. Criticism Over AI’s Role in Risk Scoring: While companies like Zing Health argue that AI complements human staff and helps manage rapid growth, critics caution that the technology is being exploited to maximize risk scores rather than improve care. Some experts argue this leads to unnecessary data collection that primarily serves financial—not patient—interests.

New Georgia law belittles teledentistry providers, telehealth group exec says

By Allison Bell - Georgia Gov. Brian Kemp has signed a bill that will establish a regulatory framework for dentists who offer teledentistry services in the state of Georgia. The Georgia Dental Association, a group for dentists, is celebrating the signing, saying the teledentistry law balances the need to expand access to care with the need to maintain quality of care. Read Full Article… (Subscription required)

HVBA Article Summary

  1. Teledentistry Restrictions in Georgia Law: The new Georgia law imposes regulations that limit the role of teledentistry, stating it should not substitute in-person care and mandating that providers meet traditional standards, including physical exams, X-rays, and medical history reviews—potentially restricting remote-only practices.

  2. Criticism from the American Telemedicine Association: The ATA strongly opposes the law, arguing it creates an anti-competitive environment favoring brick-and-mortar dental offices. They claim the law turns teledentistry into a mere referral system and unfairly implies teledentistry offers lower-quality care.

  3. Operational Barriers for Remote Providers: Key provisions require teledentistry providers to maintain a physical office in Georgia and establish local referral relationships. Critics argue these requirements undermine telehealth's flexibility and force patients into annual in-person visits, reducing accessibility and limiting patient choice.

Medicaid Payments Barely Keep Hospital Mental Health Units Afloat. Federal Cuts Could Sink Them.

By Tony Leys - This town’s hospital is a holdout on behalf of people going through mental health crises. The facility’s leaders have pledged not to shutter their inpatient psychiatric unit, as dozens of other U.S. hospitals have. Keeping that promise could soon get tougher if Congress slashes Medicaid funding. The joint federal-state health program covers an unusually large share of mental health patients, and hospital industry leaders say spending cuts could accelerate a decades-long wave of psychiatric unit closures. Read Full Article…

HVBA Article Summary

  1. Medicaid-Dependent Mental Health Services Face Financial Strain: Small hospitals like Spencer Hospital in Iowa continue operating psychiatric units despite significant losses—up to $2 million annually—because a disproportionate share of their mental health patients are either covered by Medicaid (40%) or uninsured (10%). This imbalance, driven by Medicaid’s low reimbursement rates, makes sustaining inpatient psychiatric services financially challenging, especially in rural areas.

  2. Severe Shortage of Inpatient Psychiatric Beds in Iowa: Iowa has just 760 staffed inpatient mental health beds for its 3.2 million residents—well below the “absolute minimum” of 960 recommended by mental health advocates. With only 20 of 116 community hospitals offering psychiatric units, patients often wait days in emergency departments or are transported hours away by law enforcement, further stressing local systems and leading to jail time for those in crisis.

  3. Cuts to Medicaid Could Worsen Mental Health Outcomes and Access: Nationally, Medicaid covers 41% of psychiatric inpatients, a much higher share than for other services like cancer or cardiac care. Experts warn that cuts to Medicaid or loss of coverage could delay treatment, increase emergency room visits, and contribute to rising suicide rates—especially in states that limit Medicaid expansion. Local leaders and families fear more closures will leave entire communities without critical mental health support.

Guardian adds over 20 new and innovative benefits to its hospital indemnity insurance policy, designed to inspire well-being®

By Guardian - The Guardian Life Insurance Company® (Guardian) has announced the addition of over 20 benefits to its hospital indemnity insurance offering to support holistic workforce well-being. As part of these additions, Guardian becomes the first carrier to include fertility health, family-building, and caregiving wellness solutions directly in hospital indemnity insurance. Read Full Announcement…

HVBA Article Summary

  1. Comprehensive Support Across Life Stages: Guardian has expanded its hospital indemnity insurance to include maternity payments at 36 weeks, newborn nursery benefits, and access to fertility and family-building support via Carrot—making it the first insurer to integrate these services directly into a hospital indemnity product. This aims to support employees from pregnancy through postpartum and menopause.

  2. Integrated Mental Health, Oral Care, and Caregiving Benefits: The enhanced policy includes fixed benefit payments for inpatient mental health and substance misuse treatments, an automatic payment for annual dental cleanings for Guardian dental members, and caregiving support through Wellthy. These additions reflect a broader focus on holistic well-being beyond traditional hospitalization coverage.

  3. Streamlined Access and Financial Flexibility: Guardian now offers automatic benefit payments for eligible supplemental health insurance holders when a short-term disability or paid leave claim is filed—reducing administrative burdens. The fixed benefit model helps employees cover both medical (e.g., deductibles) and non-medical (e.g., childcare, travel) costs, strengthening financial resilience during health events.